GetTopicDetailResponse(id=e38e100121c7, topicName=順鉑化療, introduction=順鉑化療, content=null, image=null, comments=0, allHits=1214, url=https://h5.medsci.cn/topic?id=100121, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=79906, tagList=[TagDto(tagId=79906, tagName=順鉑化療)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2183677, encodeId=cb2321836e73b, content=<a href='/topic/show?id=4323140286a' target=_blank style='color:#2F92EE;'>#Pembrolizumab#</a> <a href='/topic/show?id=e38e100121c7' target=_blank style='color:#2F92EE;'>#順鉑化療#</a> <a href='/topic/show?id=bb5a1104e28e' target=_blank style='color:#2F92EE;'>#肌層浸潤性尿路上皮膀胱癌#</a>, objectTitle=Eur Urol Oncol：肌層浸潤性尿路上皮膀胱癌患者中新輔助 Pembrolizumab 與順鉑化療或前期根治性膀胱切除術(shù)的療效比較, objectType=article, longId=810785, objectId=6b1e810e85e6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240124/1706071938697_1935437.jpg, objectUrl=/article/show_article.do?id=6b1e810e85e6, replyNumber=0, likeNumber=122, createdTime=2024-01-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6b1e810e85e6, moduleTitle=Eur Urol Oncol：肌層浸潤性尿路上皮膀胱癌患者中新輔助 Pembrolizumab 與順鉑化療或前期根治性膀胱切除術(shù)的療效比較, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6b1e810e85e6)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
